Hedley Rees
Pathway to Prescriptions @Pharmaflow
Signup · Get unlimited contacts
WORK HISTORY
Pathway to Prescriptions @Pharmaflow
Pathway to Prescriptions is a newsletter that follows the real journey of a medicine long before a doctor writes a script — from raw materials and global manufacturing, through regulatory filings and outsourcing decisions, to the moment a product reaches a patient’s hand. It explains how three‑year lead times, fragile supply chains, and misaligned incentives quietly shape what is safe, available, and affordable at the point of care, arming clinicians, policymakers, industry insiders and critical citizens with the insight to ask better questions about the drugs we cannot simply take back out of the body.
EDUCATION
Cranfield University School of Management
Executive MBA
University of Wales
B. Eng. (Tech) Hons, Production Engineering
Cardiff University / Prifysgol Caerdydd
B. Eng (Tech) Hons., Production Engineering
Cranfield School of Management
EMBA, Business/Commerce, General
ABOUT HEDLEY REES
Hedley Rees is Managing Consultant at PharmaFlow Ltd, a specialist consultancy challenging the status quo in pharmaceutical supply and manufacturing. He partners with pharma and biotech leaders, investors, and policymakers who recognise that today’s fragmented supply chains, outsourcing dependencies, and opaque practices are no longer fit for purpose.Working across pre-clinical, clinical, and commercial stages, Hedley helps organisations redesign end‑to‑end supply networks, rethink CDMO strategies, and build operational models that are resilient, data‑driven, and accountable to patients and society. His work shines a light on hidden risks, perverse incentives, and gaps between regulatory intent and industry behaviour.As an outspoken commentator and advocate for change, Hedley contributes to public and boardroom debates on drug shortages, reshoring, vertical integration, and regulatory reform. He is the author of Transforming the Pharmaceutical Supply Chain (Wiley, 2025) and Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics (Wiley, 2011).
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.